| BAVARIAN NORDIC |
| Dänemark |
| Gesundheit |
| DK0015998017 / 917165 |
| BV3 (Frankfurt) |
| FRA:BV3, ETR:BV3, BV3:GR |
| - |
| https://www.bavarian-nord.. |
|
Bavarian Nordic A/S is a Danish biotechnology company specializing in the research, development, manufacturing, and commercialization of innovative vaccines based on viral vector technologies. Headqua..
>Volltext.. |
| 2083.44 Mio. EUR |
| 1704.05 Mio. EUR |
| 909.85 Mio. EUR |
| 312.76 Mio. EUR |
| 324.5 Mio. EUR |
| 4.15 EUR |
| 17.79 Mio. EUR |
| 277.78 Mio. EUR |
| 415.72 Mio. EUR |
| 1.66 |
| 12.47% |
| 117.92% |
| - |
| - |
| - |
| - |
| BAVARIAN NORDIC |
| 02.03.26 |
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|